B. Riley Securities initiated coverage on GT Biopharma with a new price target
$GTBP
Biotechnology: Pharmaceutical Preparations
Health Care
B. Riley Securities initiated coverage of GT Biopharma with a rating of Buy and set a new price target of $21.00